Skip to main navigation Skip to main content

Face to face and digital

Reducing harm from PSA testing Members login for free access About RACGP online events

Details

Type: On-demand
Recorded: 19 Sep 2023

Contact

For more information:
Email: Georgie Morse
Call: 03 6212 5888

Price

RACGP Members: Free
Non-Members: Free

Watch now

Reducing harm from PSA testing

On-demand recorded 19 Sep 2023

Learning outcomes

  1. Describe the current evidence related to prevention, early detection, presentation, initial investigations, and referral for prostate cancer.
  2. Use evidence-based tools and resources to determine patients’ risk of prostate cancer and to help asymptomatic patients decide whether to proceed with PSA testing.
  3. Identify how to access local diagnostic imaging and specialist appointment referral pathways for patients presenting with signs and symptoms of prostate cancer.

This event is part of Victorian Comprehensive Cancer Centre Alliance- 3 part webinar series. Events in this series are:

Facilitator

Assoc Prof Joel Rhee
Chair RACGP Specific Interests Cancer and Palliative Care

Joel is an academic GP leading the Discipline of General Practice and Primary Care at the School of Population Health, Faculty of Medicine and Health, UNSW Sydney. He is a teacher, researcher, supervisor, and clinician with a passion for improving the delivery of care by primary healthcare professionals to people who are most in need. Especially people with palliative and supportive care needs, and people with advanced and chronic conditions, particularly cancer.

Presenters

Professor Jon Emery
Herman Professor of Primary Care Cancer Research, Director of PC4, Victorian Comprehensive Cancer Centre (VCCC) Primary Care Research and Education Lead, NHMRC Leadership Fellow

Professor Jon Emery is the Herman Professor of Primary Care Cancer Research at the University of Melbourne, a new Chair developed within the Victorian Comprehensive Cancer Centre. He is an NHMRC Practitioner Fellow, Director of the Cancer Australia Primary Care Collaborative Cancer Clinical Trials Group (PC4), and a Visiting Research Fellow at the University of Cambridge. He studied medicine at Cambridge and Oxford and obtained his DPhil at Oxford on computer decision support to assess cancer risk in general practice. His research interests are in the role of primary care in cancer prevention, diagnosis and follow-up, and primary care trials of complex interventions.

Associate Professor Niall Corcoran
Urological surgeon, Research scientist, VCCC Alliance Research & Education Lead, Genito-urinary cancer

Associate Professor Corcoran is a urological surgeon and research scientist with an interest in the molecular drivers of lethal prostate cancer and novel treatments.

In partnership with

Advertising

© 2024 The Royal Australian College of General Practitioners (RACGP) ABN 34 000 223 807